MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
Source: PRNewswire· August 10, 2026
GENEVA, Aug. 10, 2026 /PRNewswire/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today provided updates on two previously announced initiatives supporting its s…
This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire 
